Placement of the vaginal 17β-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17β-estradiol toward the uterus or periurethral areas, thereby modifying efficacy and endometrial safety

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 55-58

  Cicinelli, Ettore ^a   Di Naro, Edoardo ^a   De Ziegler, Dominique ^b   Matteo, Maria ^a   Morgese, Stella ^a   Galantino, Pietro ^a   Brioschi, Pierre Alain ^b   Schonauer, Sergio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Reproductive Endocrinology   (Switzerland)

Author keywords

Atrophy; Blood flow; Estradiol; Estrogen; Urethral vessel; Uterine artery

Indexed keywords

ESTRADIOL; VAGIFEN; FOLLITROPIN;

ARTERY BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; TABLET; VAGINA ATROPHY; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; INTRAVAGINAL DRUG ADMINISTRATION; MIDDLE AGED; PULSATILE FLOW; RANDOMIZED CONTROLLED TRIAL; URETHRA; UTERUS; VAGINA; VASCULAR RESISTANCE; VASCULARIZATION;

ADMINISTRATION, INTRAVAGINAL; CROSS-OVER STUDIES; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PULSATILE FLOW; URETHRA; UTERUS; VAGINA; VASCULAR RESISTANCE;

EID: 0037660807     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.341     Document Type: Article

References (8)

1. Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the Hormones and Urogenital Therapy (HUT) Committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:15-20
2. Weiderpass E, Baron JA, Adami HO, Magnusson C, Lindgren A, Bergstrom R, et al. Low potency estrogen and risk of endometrial cancer: a case-control study. Lancet 1999;353:1824-8.
3. Rioux JE, Devlin C, Gelfand MM, Steinberg WM. Hepburn DS. 17Beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7:156-61.
4. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293-7.
5. Cicinelli E, de Ziegler D. Transvaginal progesterone: evidence for a new functional "portal system" flowing from the vagina to the uterus. Hum Reprod Update 1999;5:365-72.
6. Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril 2001;75:200-2.
7. Cicinelli E, Einer-Jensen N, Galantino P, Pinto V, Barba B, Tartagni M. Model of counter-current transfer from vagina to urethra in postmenopausal women. Hum Reprod 2001;6:2496-500.
8. 2 administration: effects on endometrial thickness, uterine perfusion, and contractility. Fertil Steril 2001;76:994-8.